The Crick COVID-19 Consortium

Cannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune responses.

D. Meltzer, G. Randall, S. Tay, 2022, Science advances.

Scalable and robust SARS-CoV-2 testing in an academic center

The Crick COVID-19 Consortium, 2020 .

Discovery of SARS-CoV-2 main protease inhibitors using a synthesis-directed de novo design model†

J. Chodera, Alpha A Lee, S. Tay, 2021, Chemical communications.

Open Science Discovery of Oral Non-Covalent SARS-CoV-2 Main Protease Inhibitors

J. Chodera, Alpha A Lee, N. London, 2021 .

Open Science Discovery of Potent Non-Covalent SARS-CoV-2 Main Protease Inhibitors

Vincent A. Voelz, Matthew F. D. Hurley, R. Glen, 2020, bioRxiv.

Genomic epidemiology reveals multiple introductions of SARS-CoV-2 from mainland Europe into Scotland

Joshua B. Singer, A. Rambaut, D. Robertson, 2020, Nature Microbiology.

COVID Moonshot: Open Science Discovery of SARS-CoV-2 Main Protease Inhibitors by Combining Crowdsourcing, High-Throughput Experiments, Computational Simulations, and Machine Learning

J. Chodera, N. London, F. Delft, 2020 .